1. Zhong, Weiming, Xiong, Kaifen, Li, Shuwang, Li, Chuntao. . Macrophage polarization-related gene signature for risk stratification and prognosis of survival in gliomas. In Journal of cellular and molecular medicine, 28, e70000. doi:10.1111/jcmm.70000. https://pubmed.ncbi.nlm.nih.gov/39448550/
2. Wu, Haoming, Feng, Jikun, Zhong, Wenjing, Wang, Xi, Yi, Jiarong. 2023. Model for predicting immunotherapy based on M2 macrophage infiltration in TNBC. In Frontiers in immunology, 14, 1151800. doi:10.3389/fimmu.2023.1151800. https://pubmed.ncbi.nlm.nih.gov/36999020/
3. Dimitrova, Milena, Zenarruzabeitia, Olatz, Borrego, Francisco, Simhadri, Venkateswara R. 2016. CD300c is uniquely expressed on CD56 bright Natural Killer Cells and differs from CD300a upon ligand recognition. In Scientific reports, 6, 23942. doi:10.1038/srep23942. https://pubmed.ncbi.nlm.nih.gov/27040328/
4. Simhadri, Venkateswara R, Mariano, John L, Gil-Krzewska, Aleksandra, Zhou, Qing, Borrego, Francisco. 2013. CD300c is an activating receptor expressed on human monocytes. In Journal of innate immunity, 5, 389-400. doi:10.1159/000350523. https://pubmed.ncbi.nlm.nih.gov/23571507/
5. Takahashi, Mariko, Izawa, Kumi, Kashiwakura, Jun-Ichi, Kitamura, Toshio, Kitaura, Jiro. 2013. Human CD300C delivers an Fc receptor-γ-dependent activating signal in mast cells and monocytes and differs from CD300A in ligand recognition. In The Journal of biological chemistry, 288, 7662-7675. doi:10.1074/jbc.M112.434746. https://pubmed.ncbi.nlm.nih.gov/23372157/
6. Lankry, Dikla, Simic, Hrvoje, Klieger, Yair, Jonjic, Stipan, Mandelboim, Ofer. 2010. Expression and function of CD300 in NK cells. In Journal of immunology (Baltimore, Md. : 1950), 185, 2877-86. doi:10.4049/jimmunol.0903347. https://pubmed.ncbi.nlm.nih.gov/20656921/